Reading Time: 7 minutesEach year we invite plenary speakers who are experts in their fields to provide an overview on topics across MND research and clinical practice. This year we have 14 plenary speakers talking about ALS/MND who will discuss a wide range of topics from genetics to tissue biomarkers to improving clinical practice. In this second blog we will be taking a closer look at some of our plenary speakers this year and sharing more about the topics they will be discussing.
Author: Eleanor Green
I work in the Research Development team at the MND Association as a Senior Research Co-ordinator. I completed my undergraduate degree in Biomedical Science and I became very interested in neuroscience throughout my degree. Following on from this, I did a Master’s degree in Molecular Medicine, with a focus on gene therapies. As part of my role, I identify interesting updates in MND research and communicate these via the blog in an understandable and engaging way.
34th Symposium: Basel Causes and disease mechanisms Events Genetic Research Healthcare Markers of Disease Progression MND Research Models of MND Symposium
Symposium Preview: Meet the ALS/MND Plenary Speakers…Part 1
Reading Time: 7 minutesAs the research team count down to this year’s International Symposium on ALS/MND, we will be posting blogs throughout November to give you a snapshot
Reading Time: 6 minutesOn the 8 September 2023, members of the Research Development team at the MND Association attended the 4th UCL Queen Square Motor Neuron Disease Centre
Causes and disease mechanisms Genetic Research Markers of Disease Progression MND Research Models of MND Research we fund Treatments Unproven treatments
A stepping stone to becoming future leaders in MND research
Reading Time: 6 minutesMND is a very complex disease and collaboration within the research community is key to building on our current understanding of the disease biology and
Reading Time: 6 minutesQurAlis, a biotechnology company focused on developing precision medicines for MND and other neurodegenerative diseases, has announced the opening of a clinical trial in the
Reading Time: 7 minutesClinical trials are vital in the hunt for effective treatments of motor neurone disease. They provide the evidence needed to determine whether a drug is
Reading Time: 5 minutesThe MND clinical trial landscape has grown vastly over the last decade and this has led to increased opportunities for people with MND to take
Reading Time: 6 minutesTo fight motor neurone disease, we need a steady stream of enthusiastic and passionate scientists who can bring new ideas and push boundaries. Often, we
Reading Time: 6 minutesMND is a very complex disease, and in the UK there is still only one approved treatment so the need for more effective treatments remains
Reading Time: 5 minutesThe current pace of clinical trials means that there are now more trials testing potential drugs for MND in the UK than ever before. One